Clinical Trial Update: Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updates on rapid desensitization for adults with hypersensitivity reactions to Palynziq (pegvaliase) in phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria, PKU | Phase 4 | Status: ACTIVE_NOT_RECRUITING